13F Insight

Cicala Peter

CIK: 0002011534
Director
Primary company: Eterna Therapeutics Inc. (ERNA)

Cicala Peter is a corporate insider at Eterna Therapeutics Inc. (ERNA) filing SEC Form 4 transactions. 2 transactions. Source: SEC EDGAR.

Total Transactions
2
Total Buy Value
$0
Total Sell Value
$0
Net Activity
$0
Last Transaction
Feb 2025
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
51,485
Price
$0.34
Value
$18K
Type
Award
Shares
88,946
Price
-
Value
-